| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/19/2015 | WO2015023894A1 Recombinant factor viii proteins |
| 02/19/2015 | WO2015023891A2 Factor viii-xten fusions and uses thereof |
| 02/19/2015 | WO2015023890A1 Glycosylated pacap/vip analogues with enhanced cns penetration for treatment of neurodegenerative diseases |
| 02/19/2015 | WO2015023836A1 Kim-1 as a therapeutic target in conditions associated with kidney fibrosis |
| 02/19/2015 | WO2015023824A2 Cell permeable inhibitors of the scaffold protein plenty of sh3 domains (posh) or sh3rfl |
| 02/19/2015 | WO2015023811A2 Compositions and methods for identifying latently infected cells |
| 02/19/2015 | WO2015023728A1 Compositions and methods for treating celiac sprue disease |
| 02/19/2015 | WO2015023680A1 Combination therapy for the treatment of ischemia-reperfusion injury |
| 02/19/2015 | WO2015023649A2 Peptides for enhancing transdermal delivery |
| 02/19/2015 | WO2015023553A2 Contemporaneous, heterogeneously-oriented, multi-targeted therapeutic modification and/or modulation of disease by administration of sulfur- containing, amino acid-specific small molecules |
| 02/19/2015 | WO2015023132A1 Composition for treating and preventing multiple sclerosis |
| 02/19/2015 | WO2015022953A1 Blood-brain barrier disorder improvement agent |
| 02/19/2015 | WO2015022930A1 Lipid absorption promoter comprising scallop mantle protein decomposition product as active ingredient, and food and drink containing same |
| 02/19/2015 | WO2015022549A1 Map kinase p38 binding compounds |
| 02/19/2015 | WO2015022509A1 Embryo implantation |
| 02/19/2015 | WO2015022484A1 Matrix gel |
| 02/19/2015 | WO2015022447A1 Therapeutic use of vegf-c and ccbe1 |
| 02/19/2015 | WO2015022335A1 Vancomycin analogs |
| 02/19/2015 | WO2015022326A1 Peptides as active agents for treating primary graft dysfunction |
| 02/19/2015 | WO2015022192A1 Methods of modulating seed and organ size in plants |
| 02/19/2015 | WO2015021993A1 Pharmacologically active modified sb101 molecules and uses thereof |
| 02/19/2015 | WO2015021924A1 Low molecular polypeptide for preventing and treating inflammation and use thereof |
| 02/19/2015 | WO2015021904A1 Method for synthesizing glatiramer acetate |
| 02/19/2015 | WO2015021861A1 Stable insulin secretagogue peptide hydro-injection pharmaceutical composition |
| 02/19/2015 | WO2015021817A1 Use of recombinant ganoderma lucidum immunomodulatory protein (rlz-8) in preparation of medicine for treating melanoma |
| 02/19/2015 | WO2015021711A1 Improved fusion protein of human blood coagulation factor fvii-fc, preparation method therefor and use thereof |
| 02/19/2015 | WO2015021530A1 Antiviral methods and compositions comprising probiotic bacterial molecules |
| 02/19/2015 | WO2015021508A1 Regeneration of damaged tissue |
| 02/19/2015 | WO2014194429A9 Targeted enzyme compounds and uses thereof |
| 02/19/2015 | US20150051441 Embryo implantation |
| 02/19/2015 | US20150051382 Use of urodilatin for preparing a medicament for the treatment of cardiovascular, renal, pulmonary and neuronal syndrome while avoiding a rebound |
| 02/19/2015 | US20150051371 Carbohydrate-based drug delivery polymers and conjugates thereof |
| 02/19/2015 | US20150051268 Methods of increasing the viability or longevity of an organ or organ explant |
| 02/19/2015 | US20150051161 Methods for the Detection of Advanced Glycation Endproducts and Markers for Disease |
| 02/19/2015 | US20150051160 Tyrosine based linkers for the releasable connection of peptides |
| 02/19/2015 | US20150051159 Lactococcus lactis strains |
| 02/19/2015 | US20150051157 Romidepsin formulations and uses thereof |
| 02/19/2015 | US20150051156 Method of treating leukemia using rice prolamin |
| 02/19/2015 | US20150051154 Alkylating agents |
| 02/19/2015 | US20150051153 Environmentally Sensitive Compositions |
| 02/19/2015 | US20150051150 Compositions, methods and assays comprising amylin or amlyin analogs for abeta-peptide mediated disorders |
| 02/19/2015 | US20150051147 Methods for treating hidradenitis suppurativa |
| 02/19/2015 | US20150051146 Hb-egf inhibitor derived from the r domain of diphtheria toxin for the treatment of diseases associated with the activation of the hb-egf/egfr pathway |
| 02/19/2015 | US20150051142 Novel method for peroral delivery of insulin and its analogues for therapeutic usage |
| 02/19/2015 | US20150051140 Modification of feeding behavior |
| 02/19/2015 | US20150051139 Mucins as Antiviral Compounds |
| 02/19/2015 | US20150051137 Peptide and uses therefor |
| 02/19/2015 | US20150050716 Novel adamts-13 mutant |
| 02/19/2015 | US20150050617 Methods For Extracting A Tooth |
| 02/19/2015 | US20150050331 Method for making a topical composition comprising growth factors derived from human umbilical cord blood platelets |
| 02/19/2015 | US20150050289 Muscle specific receptor kinase and modulation thereof |
| 02/19/2015 | US20150050277 Compositions and methods for treating ocular diseases |
| 02/19/2015 | US20150050262 Oligosaccharides comprising an aminooxy group and conjugates thereof |
| 02/19/2015 | US20150050240 Treatment of fibrosis |
| 02/19/2015 | US20150050215 Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease |
| 02/19/2015 | US20150050212 Cholecystokinin b receptor targeting for imaging and therapy |
| 02/18/2015 | EP2837392A2 Modified erythropoietin to which water-soluble long-chain molecule is added |
| 02/18/2015 | EP2837384A1 Glutathione based delivery system |
| 02/18/2015 | EP2837383A1 Immunity-inducing agent |
| 02/18/2015 | EP2837373A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof |
| 02/18/2015 | EP2836228A1 Combination of somatostatin-analogs with 11beta-hydroxylase inhibitors |
| 02/18/2015 | EP2836227A1 Aromatic-cationic peptides and uses of same |
| 02/18/2015 | EP2836226A1 Compositions and methods for the treatment of hemoglobinopathies |
| 02/18/2015 | EP2836214A1 Bruton's tyrosine kinase inhibitors for hematopoietic mobilization |
| 02/18/2015 | EP2836206A2 Controlled release pharmaceutical formulations of direct thrombin inhibitors |
| 02/18/2015 | EP2836195A1 System and method for multiphasic release of growth factors |
| 02/18/2015 | EP2836194A2 Cosmetic composition comprising a muconopeptide |
| 02/17/2015 | US8958879 Swallowable capsule and method for stimulating incretin production within the intestinal tract |
| 02/17/2015 | US8957203 Hepatitis C virus inhibitors |
| 02/17/2015 | US8957185 MUC-1 cytoplasmic domain peptides as inhibitors of cancer |
| 02/17/2015 | US8957184 Pro-apoptotic peptides |
| 02/17/2015 | US8957076 Wound healing |
| 02/17/2015 | US8957036 Targeted delivery of glycine receptors to excitable cells |
| 02/17/2015 | US8957032 Inhibition of gliadin peptides |
| 02/17/2015 | US8957031 Competitive inhibitors of invariant chain expression and/or ectopic clip binding |
| 02/17/2015 | US8957030 Methods for preventing or treating mitochondrial permeability transition |
| 02/17/2015 | US8957029 Peptide for determining actin structures in living cells |
| 02/17/2015 | US8957028 Red-shifted opsin molecules and uses thereof |
| 02/17/2015 | US8957027 Deacetylase inhibitor therapy |
| 02/17/2015 | US8957026 Beta-catenin targeting peptides and uses thereof |
| 02/17/2015 | US8957025 Enkephalin analogues |
| 02/17/2015 | US8957024 Composition and methods for reducing opioid-induced pruritus |
| 02/17/2015 | US8957023 Methods for making proteins containing free cysteine residues |
| 02/17/2015 | US8957022 Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis |
| 02/17/2015 | US8957021 Glucose-regulating polypeptides and methods of making and using same |
| 02/17/2015 | US8957020 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 02/17/2015 | US8957019 Oligopeptide for treating liver fibrosis and/or treating hepatitis B and/or improving liver function |
| 02/17/2015 | US8957018 Recombinant human CC10 protein for treatment of influenza |
| 02/17/2015 | US8957017 Dipeptoid prodrugs and their use |
| 02/17/2015 | US8957016 Tumor activated prodrugs |
| 02/17/2015 | US8957015 Tumor suppressor gene p47ING3 |
| 02/17/2015 | US8957014 Sensitization of tumor cells to radiation therapy through administration of endothelin agonists |
| 02/17/2015 | US8957013 Receptors useful for gas phase chemical sensing |
| 02/17/2015 | US8957012 Gamma secretase inhibitor for treatment of herpesvirus infection |
| 02/17/2015 | US8956878 Polypeptides with affinity for heat shock proteins (HSPS) and HSP associated complexes (HACS) and their use in diagnosis and therapy |
| 02/17/2015 | US8956863 Agents from cells |
| 02/17/2015 | US8956847 Fusion proteins |
| 02/17/2015 | US8956828 Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases |
| 02/17/2015 | US8956825 Intranuclear protein transduction through a nucleoside salvage pathway |
| 02/17/2015 | US8956645 Water-soluble pharmaceutical composition comprising at least one therapeutically active substance having hydrophobic properties and at least one compound selected from among sialoglycosphingolipids, glycosphingolipids or a mixture of sialoglycosphingolipids and glycosphingolipids |